Receptor-targeted peptide conjugates based on diphosphines enable preparation of 99mTc and 188Re theranostic agents for prostate cancer

Research output: Contribution to journalArticlepeer-review

47 Downloads (Pure)
Original languageEnglish
JournalJournal of Nuclear Medicine
DOIs
Publication statusAccepted/In press - 29 Apr 2024

Cite this